NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
9.25
-0.37 (-3.85%)
At close: Apr 28, 2026, 4:00 PM EDT
9.25
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:29 PM EDT
NextCure Employees
NextCure had 40 employees as of December 31, 2025. The number of employees decreased by 3 or -6.98% compared to the previous year.
Employees
40
Change (1Y)
-3
Growth (1Y)
-6.98%
Revenue / Employee
n/a
Profits / Employee
-$1,396,100
Market Cap
32.93M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Aligos Therapeutics | 82 |
| Werewolf Therapeutics | 39 |
| Palatin Technologies | 29 |
| Actinium Pharmaceuticals | 25 |
| INmune Bio | 21 |
| Veru Inc. | 20 |
| RenovoRx | 17 |
| CervoMed | 15 |
NXTC News
- 7 days ago - NextCure and Simcere's SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026 - GlobeNewsWire
- 21 days ago - NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer - GlobeNewsWire
- 4 weeks ago - NextCure and Simcere's SIM0505 (CDH6 ADC) Abstract Accepted for ASCO 2026 - GlobeNewsWire
- 7 weeks ago - NextCure Provides Business Update and Reports Full Year 2025 Financial Results - GlobeNewsWire
- 3 months ago - NextCure Provides Business Update - GlobeNewsWire
- 5 months ago - NextCure Transcript: Piper Sandler 37th Annual Healthcare Conference - Transcripts
- 5 months ago - NextCure to Present at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 5 months ago - NextCure Announces Closing of $21.5 Million PIPE Financing in Advance of First Half 2026 Phase 1 POC Data Readouts - GlobeNewsWire